(AIR) Airbus SE - Overview
Exchange: PA •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000235190
Stock: Aircraft, Helicopters, Space Systems, Defense
Total Rating 41
Risk 77
Buy Signal -0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 33.3% |
| Relative Tail Risk | -5.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -14.06 |
| Character TTM | |
|---|---|
| Beta | 0.723 |
| Beta Downside | 0.324 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.92% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Description: AIR Airbus SE March 04, 2026
Airbus SE designs, manufactures, and delivers aeronautics and aerospace products and services globally. The company operates in three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space.
The Airbus segment focuses on commercial jet passenger and freighter aircraft, regional turboprops, and aircraft components, including conversion and related services. The commercial aircraft sector is characterized by long development cycles and high capital expenditure.
Airbus Helicopters develops and sells civil and military helicopters, alongside uncrewed aerial systems and associated services. The global helicopter market serves diverse applications from transport to emergency services and defense.
The Airbus Defence and Space segment provides crewed and uncrewed military air systems, civil and defense space systems for various applications (telecommunications, earth observation, navigation, science), and services encompassing data processing, secure communication, and cybersecurity. The defense and space industry often involves government contracts and advanced technological innovation.
For more detailed financial and operational insights, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Commercial aircraft orders drive revenue growth
- Supply chain disruptions increase production costs
- Defense spending impacts military aircraft sales
- Geopolitical tensions influence aerospace demand
- Regulatory approvals crucial for new aircraft models
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 5.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.04 > 1.0 |
| NWC/Revenue: 12.90% < 20% (prev 12.72%; Δ 0.18% < -1%) |
| CFO/TA 0.06 > 3% & CFO 8.01b > Net Income 5.22b |
| Net Debt (2.17b) to EBITDA (9.49b): 0.23 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (790.9m) vs 12m ago 0.00% < -2% |
| Gross Margin: 14.94% > 18% (prev 0.15%; Δ 1.48k% > 0.5%) |
| Asset Turnover: 55.59% > 50% (prev 53.58%; Δ 2.01% > 0%) |
| Interest Coverage Ratio: 8.26 > 6 (EBITDA TTM 9.49b / Interest Expense TTM 770.0m) |
Altman Z'' 1.55
| A: 0.07 (Total Current Assets 72.90b - Total Current Liabilities 63.43b) / Total Assets 134.94b |
| B: 0.17 (Retained Earnings 22.33b / Total Assets 134.94b) |
| C: 0.05 (EBIT TTM 6.36b / Avg Total Assets 132.08b) |
| D: 0.21 (Book Value of Equity 23.06b / Total Liabilities 108.75b) |
| Altman-Z'' Score: 1.55 = BB |
Beneish M -2.74
| DSRI: 1.31 (Receivables 10.99b/7.93b, Revenue 73.42b/69.23b) |
| GMI: 1.03 (GM 14.94% / 15.42%) |
| AQI: 0.97 (AQ_t 0.30 / AQ_t-1 0.31) |
| SGI: 1.06 (Revenue 73.42b / 69.23b) |
| TATA: -0.02 (NI 5.22b - CFO 8.01b) / TA 134.94b) |
| Beneish M-Score: -2.74 (Cap -4..+1) = A |
What is the price of AIR shares?
As of March 24, 2026, the stock is trading at EUR 166.40 with a total of 2,108,959 shares traded.
Over the past week, the price has changed by -2.09%, over one month by -9.14%, over three months by -15.41% and over the past year by +1.80%.
Over the past week, the price has changed by -2.09%, over one month by -9.14%, over three months by -15.41% and over the past year by +1.80%.
Is AIR a buy, sell or hold?
Airbus SE has no consensus analysts rating.
What are the forecasts/targets for the AIR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 219.6 | 31.9% |
| Analysts Target Price | - | - |
AIR Fundamental Data Overview March 24, 2026
Market Cap USD = 146.85b (127.01b EUR * 1.1562 EUR.USD)
P/E Trailing = 24.3818
P/E Forward = 22.0264
P/S = 1.7299
P/B = 4.8529
P/EG = 1.388
Revenue TTM = 73.42b EUR
EBIT TTM = 6.36b EUR
EBITDA TTM = 9.49b EUR
Long Term Debt = 10.63b EUR (from longTermDebt, last quarter)
Short Term Debt = 5.19b EUR (from shortTermDebt, last quarter)
Debt = 16.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.17b EUR (from netDebt column, last quarter)
Enterprise Value = 136.57b EUR (127.01b + Debt 16.30b - CCE 6.74b)
Interest Coverage Ratio = 8.26 (Ebit TTM 6.36b / Interest Expense TTM 770.0m)
EV/FCF = 33.75x (Enterprise Value 136.57b / FCF TTM 4.05b)
FCF Yield = 2.96% (FCF TTM 4.05b / Enterprise Value 136.57b)
FCF Margin = 5.51% (FCF TTM 4.05b / Revenue TTM 73.42b)
Net Margin = 7.11% (Net Income TTM 5.22b / Revenue TTM 73.42b)
Gross Margin = 14.94% ((Revenue TTM 73.42b - Cost of Revenue TTM 62.45b) / Revenue TTM)
Gross Margin QoQ = 14.59% (prev 16.42%)
Tobins Q-Ratio = 1.01 (Enterprise Value 136.57b / Total Assets 134.94b)
Interest Expense / Debt = 1.26% (Interest Expense 206.0m / Debt 16.30b)
Taxrate = 6.89% (180.0m / 2.61b)
NOPAT = 5.92b (EBIT 6.36b * (1 - 6.89%))
Current Ratio = 1.15 (Total Current Assets 72.90b / Total Current Liabilities 63.43b)
Debt / Equity = 0.62 (Debt 16.30b / totalStockholderEquity, last quarter 26.10b)
Debt / EBITDA = 0.23 (Net Debt 2.17b / EBITDA 9.49b)
Debt / FCF = 0.54 (Net Debt 2.17b / FCF TTM 4.05b)
Total Stockholder Equity = 24.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 5.22b / Total Assets 134.94b)
RoE = 21.22% (Net Income TTM 5.22b / Total Stockholder Equity 24.60b)
RoCE = 18.05% (EBIT 6.36b / Capital Employed (Equity 24.60b + L.T.Debt 10.63b))
RoIC = 18.25% (NOPAT 5.92b / Invested Capital 32.44b)
WACC = 7.69% (E(127.01b)/V(143.31b) * Re(8.53%) + D(16.30b)/V(143.31b) * Rd(1.26%) * (1-Tc(0.07)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.07%
[DCF] Terminal Value 81.01% ; FCFF base≈4.00b ; Y1≈4.44b ; Y5≈5.82b
[DCF] Fair Price = 135.5 (EV 108.83b - Net Debt 2.17b = Equity 106.65b / Shares 787.2m; r=7.69% [WACC]; 5y FCF grow 12.80% → 3.0% )
EPS Correlation: 26.22 | EPS CAGR: 26.75% | SUE: 2.40 | # QB: 2
Revenue Correlation: 52.32 | Revenue CAGR: 22.88% | SUE: -0.96 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.71 | Chg7d=-0.067 | Chg30d=+0.778 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=7.20 | Chg7d=+0.011 | Chg30d=-0.622 | Revisions Net=-16 | Growth EPS=+4.5% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=8.66 | Chg7d=-0.029 | Chg30d=-0.823 | Revisions Net=-13 | Growth EPS=+20.3% | Growth Revenue=+11.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 8.5% - Earnings Yield 4.1%)
[Growth] Growth Spread = +10.7% (Analyst 15.1% - Implied 4.4%)
P/E Trailing = 24.3818
P/E Forward = 22.0264
P/S = 1.7299
P/B = 4.8529
P/EG = 1.388
Revenue TTM = 73.42b EUR
EBIT TTM = 6.36b EUR
EBITDA TTM = 9.49b EUR
Long Term Debt = 10.63b EUR (from longTermDebt, last quarter)
Short Term Debt = 5.19b EUR (from shortTermDebt, last quarter)
Debt = 16.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.17b EUR (from netDebt column, last quarter)
Enterprise Value = 136.57b EUR (127.01b + Debt 16.30b - CCE 6.74b)
Interest Coverage Ratio = 8.26 (Ebit TTM 6.36b / Interest Expense TTM 770.0m)
EV/FCF = 33.75x (Enterprise Value 136.57b / FCF TTM 4.05b)
FCF Yield = 2.96% (FCF TTM 4.05b / Enterprise Value 136.57b)
FCF Margin = 5.51% (FCF TTM 4.05b / Revenue TTM 73.42b)
Net Margin = 7.11% (Net Income TTM 5.22b / Revenue TTM 73.42b)
Gross Margin = 14.94% ((Revenue TTM 73.42b - Cost of Revenue TTM 62.45b) / Revenue TTM)
Gross Margin QoQ = 14.59% (prev 16.42%)
Tobins Q-Ratio = 1.01 (Enterprise Value 136.57b / Total Assets 134.94b)
Interest Expense / Debt = 1.26% (Interest Expense 206.0m / Debt 16.30b)
Taxrate = 6.89% (180.0m / 2.61b)
NOPAT = 5.92b (EBIT 6.36b * (1 - 6.89%))
Current Ratio = 1.15 (Total Current Assets 72.90b / Total Current Liabilities 63.43b)
Debt / Equity = 0.62 (Debt 16.30b / totalStockholderEquity, last quarter 26.10b)
Debt / EBITDA = 0.23 (Net Debt 2.17b / EBITDA 9.49b)
Debt / FCF = 0.54 (Net Debt 2.17b / FCF TTM 4.05b)
Total Stockholder Equity = 24.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 5.22b / Total Assets 134.94b)
RoE = 21.22% (Net Income TTM 5.22b / Total Stockholder Equity 24.60b)
RoCE = 18.05% (EBIT 6.36b / Capital Employed (Equity 24.60b + L.T.Debt 10.63b))
RoIC = 18.25% (NOPAT 5.92b / Invested Capital 32.44b)
WACC = 7.69% (E(127.01b)/V(143.31b) * Re(8.53%) + D(16.30b)/V(143.31b) * Rd(1.26%) * (1-Tc(0.07)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.07%
[DCF] Terminal Value 81.01% ; FCFF base≈4.00b ; Y1≈4.44b ; Y5≈5.82b
[DCF] Fair Price = 135.5 (EV 108.83b - Net Debt 2.17b = Equity 106.65b / Shares 787.2m; r=7.69% [WACC]; 5y FCF grow 12.80% → 3.0% )
EPS Correlation: 26.22 | EPS CAGR: 26.75% | SUE: 2.40 | # QB: 2
Revenue Correlation: 52.32 | Revenue CAGR: 22.88% | SUE: -0.96 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.71 | Chg7d=-0.067 | Chg30d=+0.778 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=7.20 | Chg7d=+0.011 | Chg30d=-0.622 | Revisions Net=-16 | Growth EPS=+4.5% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=8.66 | Chg7d=-0.029 | Chg30d=-0.823 | Revisions Net=-13 | Growth EPS=+20.3% | Growth Revenue=+11.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 8.5% - Earnings Yield 4.1%)
[Growth] Growth Spread = +10.7% (Analyst 15.1% - Implied 4.4%)